These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 16325128)
1. Antiangiogenic therapies for mesothelioma. Dowell JE; Kindler HL Hematol Oncol Clin North Am; 2005 Dec; 19(6):1137-45, viii. PubMed ID: 16325128 [TBL] [Abstract][Full Text] [Related]
2. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results. Pass HI; Brewer GJ; Dick R; Carbone M; Merajver S Ann Thorac Surg; 2008 Aug; 86(2):383-9; discussion 390. PubMed ID: 18640301 [TBL] [Abstract][Full Text] [Related]
3. Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments. Catalano A; Gianni W; Procopio A Crit Rev Oncol Hematol; 2004 May; 50(2):101-9. PubMed ID: 15157659 [TBL] [Abstract][Full Text] [Related]
4. Targeting angiogenesis with integrative cancer therapies. Yance DR; Sagar SM Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711 [TBL] [Abstract][Full Text] [Related]
6. [Inhibitors of neoangiogenesis in antineoplastic therapy]. Opolski A; Wietrzyk J Postepy Hig Med Dosw; 2001; 55(3):369-85. PubMed ID: 11505638 [TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and gliomas: current issues and development of surrogate markers. Jouanneau E Neurosurgery; 2008 Jan; 62(1):31-50; discussion 50-2. PubMed ID: 18300890 [TBL] [Abstract][Full Text] [Related]
8. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer. Ademuyiwa FO; Miller KD Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035 [TBL] [Abstract][Full Text] [Related]
9. [Angiogenesis: all a radiation oncologist should know]. Mazeron R; Bourhis J; Deutsch E Cancer Radiother; 2008 Jan; 12(1):50-60. PubMed ID: 18243753 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors. Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539 [TBL] [Abstract][Full Text] [Related]
11. Targeting angiogenesis in head and neck cancer. Seiwert TY; Cohen EE Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?]. Reck M; Heigener DF; Gatzemeier U Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688 [TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Pang R; Poon RT Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617 [TBL] [Abstract][Full Text] [Related]
14. Angiogenesis inhibitors in the treatment of lung cancer. Sun S; Schiller JH Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557 [TBL] [Abstract][Full Text] [Related]
15. An overview of chemotherapy for mesothelioma. Krug LM Hematol Oncol Clin North Am; 2005 Dec; 19(6):1117-36, vii. PubMed ID: 16325127 [TBL] [Abstract][Full Text] [Related]
16. Will antiangiogenic agents be a future for mesothelioma therapy? Belli C; Anand S; Panella M; Giovannini M; Tassi G; Fennell D; Mutti L Curr Med Chem; 2010; 17(27):3069-79. PubMed ID: 20629625 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266 [TBL] [Abstract][Full Text] [Related]
20. Radiation combined with antiangiogenic and antivascular agents. O'Reilly MS Semin Radiat Oncol; 2006 Jan; 16(1):45-50. PubMed ID: 16378906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]